Concepedia

Lilach Vaks

LV

Statistics

Publications

7

Citations

694

H-Index

7

Active since

2011

Affiliations

Tel Aviv University(Current)

Lilach Vaks is an author at Tel Aviv University specializing in pharmacy, neurodegeneration, and life sciences.

Publications per year

2011–2021

7

Publications

7

Phenylalanine assembly into toxic fibrils suggests amyloid etiology in phenylketonuria

Lihi Adler‐Abramovich, Lilach Vaks, Ohad Carny et al. · Nature Chemical Biology · 2012 · 467 citations

Life Sciences, Biochemistry, Molecular Biology +16

A unique type of GSK-3 inhibitor brings new opportunities to the clinic

Avital Licht-Murava, Rom Paz, Lilach Vaks et al. · Science Signaling · 2016 · 72 citations

Life Sciences, Medicinal Chemistry, Pharmacology +17

In vivo characteristics of targeted drug-carrying filamentous bacteriophage nanomedicines

Lilach Vaks, Itai Benhar · Journal of Nanobiotechnology · 2011 · 68 citations · Full text

Pharmacy, Pharmaceutics, Pharmacokinetics +17

Inhibition of GSK-3 ameliorates the pathogenesis of Huntington's disease

Ido Rippin, Katherina Bonder, Shirley Joseph et al. · Neurobiology of Disease · 2021 · 29 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Production of Stabilized scFv Antibody Fragments in the E. coli Bacterial Cytoplasm

Lilach Vaks, Itai Benhar · Methods in molecular biology · 2013 · 27 citations

Pharmacy, Biotechnology, Molecular Biology +14

1–5 of 7